Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CAPR Capricor Therapeutics Inc

未开盘 12-18 16:00:00 EST

12.52

-0.68

-5.15%

盘后12.88

+0.36+2.88%

19:48 EST

最高13.66	最低12.25	成交量115.64万
今开13.13	昨收13.20	日振幅10.68%
总市值5.69亿	流通市值5.00亿	总股本4,547万
成交额1,464万	换手率2.89%	流通股本3,996万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CAPR","market":"US","secType":"STK","nameCN":"Capricor Therapeutics Inc","latestPrice":12.52,"timestamp":1734555600000,"preClose":13.2,"halted":0,"volume":1156390,"hourTrading":{"tag":"盘后","latestPrice":12.88,"preClose":12.52,"latestTime":"19:48 EST","volume":21719,"amount":272711.5517,"timestamp":1734569324342},"delay":0,"floatShares":39962779,"shares":45469908,"eps":-1.074378,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.68,"latestTime":"12-18 16:00:00 EST","open":13.13,"high":13.66,"low":12.25,"amount":14638475.0403,"amplitude":0.106818,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.074378,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734598800000},"adr":0,"adjPreClose":13.2,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":13.22,"preClose":13.2,"latestTime":"09:29 EST","volume":896,"amount":12087.509504000001,"timestamp":1734532171097},"postHourTrading":{"tag":"盘后","latestPrice":12.88,"preClose":12.52,"latestTime":"19:48 EST","volume":21719,"amount":272711.5517,"timestamp":1734569324342},"volumeRatio":1.169527,"impliedVol":1.6802,"impliedVolPercentile":0.8406},"requestUrl":"/m/hq/s/CAPR","defaultTab":"news","newsList":[{"id":"2492612717","title":"Capricor Therapeutics, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492612717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492612717?lang=zh_cn&edition=full","pubTime":"2024-12-17 01:11","pubTimestamp":1734369082,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日01时11分，Capricor Therapeutics, Inc.股票出现异动，股价急速拉升5.02%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217011122984c73d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217011122984c73d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","BK4139","LENZ"],"gpt_icon":0},{"id":"2491051843","title":"Capricor Therapeutics, Inc.盘中异动 快速跳水5.09%报13.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491051843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491051843?lang=zh_cn&edition=full","pubTime":"2024-12-14 01:34","pubTimestamp":1734111268,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日01时34分，Capricor Therapeutics, Inc.股票出现波动，股价大幅下跌5.09%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。Deramiocel 目前正处于治疗杜氏肌营养不良症的 3 期临床开发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214013429ab75dca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214013429ab75dca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","BK4139","LENZ"],"gpt_icon":0},{"id":"2489379239","title":"Capricor Therapeutics, Inc.盘中异动 快速上涨5.23%报15.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489379239","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489379239?lang=zh_cn&edition=full","pubTime":"2024-12-06 22:34","pubTimestamp":1733495662,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日22时34分，Capricor Therapeutics, Inc.股票出现异动，股价急速上涨5.23%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。Deramiocel 目前正处于治疗杜氏肌营养不良症的 3 期临床开发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223422a1d970af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206223422a1d970af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAPR","LENZ"],"gpt_icon":0},{"id":"1120740922","title":"异动解读 | Capricor Therapeutics股价 盘中大涨22.44% 罕见病新药临床前景看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1120740922","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120740922?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:08","pubTimestamp":1733411329,"startTime":"0","endTime":"0","summary":"生物技术企业Capricor Therapeutics Inc 今日盘中股价大涨22.44%,引发市场关注。分析人士指出,该股价大涨或与公司正在研发的针对罕见疾病的新药临床前景被看好有关。Capricor目前主要产品CAP-1002和deramiocel正处于临床开发阶段,拟用于治疗杜氏肌营养不良症。总体而言,投资者预期Capricor Therapeutics在研药物和创新技术平台未来可能带来较大的回报和增长空间,因而对其长期发展前景抱有信心,推动了该股价格的大幅上涨。但具体引发这一涨幅的消息还有待进一步跟踪和了解。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Capricor Therapeutics股价 盘中大涨22.44% 罕见病新药临床前景看好","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CAPR"],"gpt_icon":0},{"id":"2489457290","title":"Capricor Therapeutics, Inc.股价飙升16.12% 市值涨1.08亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489457290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489457290?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:32","pubTimestamp":1733409126,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时32分，Capricor Therapeutics, Inc.股票出现波动，股价大幅拉升16.12%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Protara Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Psyence Biomedical Ltd.、Protara Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1757.73%、240.08%、206.65%，振幅较大的相关个股有Protara Therapeutics, Inc.、Psyence Biomedical Ltd.、Biomx Inc.，振幅分别为36.44%、18.25%、10.98%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223206ab5ffd80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223206ab5ffd80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAPR","LENZ"],"gpt_icon":0},{"id":"2488750945","title":"Capricor Therapeutics, Inc.盘中异动 股价大涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488750945","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488750945?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:34","pubTimestamp":1733236461,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时34分，Capricor Therapeutics, Inc.股票出现波动，股价大幅上涨5.50%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Janux Therapeutics, Inc.、Coherus Biosciences, Inc.、Cytomx Therapeutics, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为129.84%、64.69%、54.19%，振幅较大的相关个股有Coherus Biosciences, Inc.、万春医药、Cabaletta Bio, Inc.，振幅分别为24.09%、13.02%、12.35%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223421a269971e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223421a269971e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CAPR"],"gpt_icon":0},{"id":"2488988370","title":"Capricor Therapeutics, Inc.盘中异动 急速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488988370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488988370?lang=zh_cn&edition=full","pubTime":"2024-12-03 03:56","pubTimestamp":1733169360,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日03时56分，Capricor Therapeutics, Inc.股票出现异动，股价快速拉升5.04%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Senti Biosciences, Inc.、Purple Biotech Ltd、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Purple Biotech Ltd、Senti Biosciences, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2891.44%、2675.09%、663.42%，振幅较大的相关个股有Senti Biosciences, Inc.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd，振幅分别为481.02%、289.12%、131.67%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120303560198e4f5ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120303560198e4f5ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2486488410","title":"Capricor Therapeutics, Inc.盘中异动 急速上涨5.18%报19.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486488410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486488410?lang=zh_cn&edition=full","pubTime":"2024-11-27 01:52","pubTimestamp":1732643543,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日01时52分，Capricor Therapeutics, Inc.股票出现异动，股价急速拉升5.18%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。Deramiocel 目前正处于治疗杜氏肌营养不良症的 3 期临床开发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127015223971a8b1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127015223971a8b1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2485866213","title":"Capricor Therapeutics, Inc.盘中异动 大幅上涨5.06%报18.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485866213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485866213?lang=zh_cn&edition=full","pubTime":"2024-11-23 02:56","pubTimestamp":1732301784,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日02时56分，Capricor Therapeutics, Inc.股票出现波动，股价快速拉升5.06%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。Deramiocel 目前正处于治疗杜氏肌营养不良症的 3 期临床开发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123025624a24e8b00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123025624a24e8b00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CAPR"],"gpt_icon":0},{"id":"2485298972","title":"Capricor Therapeutics, Inc.2024财年第三财季实现净利润-12.56百万美元，同比减少96.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298972?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:00","pubTimestamp":1732291256,"startTime":"0","endTime":"0","summary":"11月23日，Capricor Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-12.56百万美元，同比减少96.56%；其中营业收入为2.26百万美元，同比减少63.49%，每股基本收益为-0.38美元。机构评级：截至2024年11月23日，当前有7家机构对Capricor Therapeutics, Inc.目标价做出预测，其中目标均价为41.29美元，其中最低目标价为25.00美元，最高目标价为77.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000116abd7b837&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000116abd7b837&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CAPR"],"gpt_icon":0},{"id":"2485149604","title":"Capricor Therapeutics, Inc.盘中异动 快速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485149604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485149604?lang=zh_cn&edition=full","pubTime":"2024-11-21 00:02","pubTimestamp":1732118534,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日00时02分，Capricor Therapeutics, Inc.股票出现异动，股价大幅拉升5.04%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc是一家总部设在美国的生物技术公司，专注于发现、开发和商业化用于治疗疾病的一流生物疗法，重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112100021498e43c5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112100021498e43c5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2484676521","title":"Capricor Therapeutics, Inc.盘中异动 股价大跌5.05%报17.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484676521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484676521?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:40","pubTimestamp":1731940848,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时40分，Capricor Therapeutics, Inc.股票出现波动，股价大幅跳水5.05%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc是一家总部设在美国的生物技术公司，专注于发现、开发和商业化用于治疗疾病的一流生物疗法，重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822404998e4341a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822404998e4341a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CAPR"],"gpt_icon":0},{"id":"2484661939","title":"美国研究综述-Airbnb、Post Holdings、Syndax Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2484661939","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484661939?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:15","pubTimestamp":1731914144,"startTime":"0","endTime":"0","summary":"美国研究综述-Airbnb、Post Holdings、Syndax Pharmaceuticals路透11月18日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 Airbnb、Post Holdings 和 Syndax Pharmaceuticals。* Post Holdings Inc POST.N：摩根大通将目标价从125美元上调至135美元 * Syndax Pharmaceuticals Inc SNDX.O：杰富瑞将目标价从37美元上调至43美元 * Transmedics Group Inc TMDX.O：TD Cowen将目标价从175美元下调至120美元以下是路透周一报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nL4S3MP0GY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADSK","LU0543330483.HKD","MBI","TARS","BK4503","IE00BZ08YT58.USD","LU1196710864.SGD","HBBD.SI","PLD","LU0348788117.USD","LU0287142896.SGD","LU1105468828.SGD","LU1983260115.SGD","LU0228367735.SGD","LU0898667661.SGD","LU0543330566.HKD","LU0737861772.HKD","PGR","BK1521","LU0051755006.USD","CAPR","TMDX","LU1481107354.HKD","LU0345776255.USD","SNDX","IE00BZ08YR35.GBP","LU2355687059.USD","BABA","HK0000306701.USD","LU1023057109.AUD","EFXT","LU0541502299.USD","LU0293314216.USD","IE00BFMHRM44.USD","LU0516422440.USD","PCOR","IE00B19Z9Z06.USD","09988","KRRO","ABNB","LU1688375341.USD","LU1439103000.SGD","LU1048588211.SGD","POST","LU0251144936.SGD","OVV","89988","YELP","INO","BK1502"],"gpt_icon":1},{"id":"2483683096","title":"Capricor Therapeutics, Inc.盘中异动 股价大跌5.03%报17.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483683096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483683096?lang=zh_cn&edition=full","pubTime":"2024-11-14 01:59","pubTimestamp":1731520781,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日01时59分，Capricor Therapeutics, Inc.股票出现波动，股价急速下挫5.03%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc是一家总部设在美国的生物技术公司，专注于发现、开发和商业化用于治疗疾病的一流生物疗法，重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114015941a234bfe2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114015941a234bfe2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAPR","LENZ"],"gpt_icon":0},{"id":"2482757714","title":"Capricor Therapeutics Inc   预计每股亏损36美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482757714","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482757714?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:50","pubTimestamp":1731383458,"startTime":"0","endTime":"0","summary":"   * Capricor Therapeutics Inc    将于11月13日公布截至0001年1月1日的季度业绩报告，预计该公司的季度收入将出现下降。* LSEG 分析师对 Capricor Therapeutics Inc 的平均预期是每股亏损 36 美分。* 华尔街对 Capricor Therapeutics Inc 的 12 个月目标价中位数为 30.00 美元，高于其最新收盘价 19.54 美元。11月12日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPR","LENZ"],"gpt_icon":0},{"id":"2480068944","title":"Capricor Therapeutics, Inc.盘中异动 股价大跌5.02%报20.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480068944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480068944?lang=zh_cn&edition=full","pubTime":"2024-11-01 02:56","pubTimestamp":1730400960,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日02时56分，Capricor Therapeutics, Inc.股票出现波动，股价快速跳水5.02%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.38%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc是一家总部设在美国的生物技术公司，专注于发现、开发和商业化用于治疗疾病的一流生物疗法，重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101025600a2038667&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101025600a2038667&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CAPR"],"gpt_icon":0},{"id":"2478930264","title":"Capricor Therapeutics, Inc.盘中异动 急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478930264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478930264?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:10","pubTimestamp":1729869011,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日23时10分，Capricor Therapeutics, Inc.股票出现异动，股价大幅拉升5.00%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc是一家总部设在美国的生物技术公司，专注于发现、开发和商业化用于治疗疾病的一流生物疗法，重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025231011ab743247&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025231011ab743247&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"gpt_icon":0},{"id":"2477755936","title":"Capricor Therapeutics, Inc.盘中异动 股价大涨5.01%报21.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477755936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477755936?lang=zh_cn&edition=full","pubTime":"2024-10-24 01:01","pubTimestamp":1729702864,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日01时01分，Capricor Therapeutics, Inc.股票出现异动，股价急速上涨5.01%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.06%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc是一家总部设在美国的生物技术公司，专注于发现、开发和商业化用于治疗疾病的一流生物疗法，重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102401010598e3e0b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102401010598e3e0b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CAPR"],"gpt_icon":0},{"id":"2477610218","title":"Capricor Therapeutics, Inc.盘中异动 大幅拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477610218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477610218?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:39","pubTimestamp":1729521549,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时39分，Capricor Therapeutics, Inc.股票出现异动，股价快速上涨5.36%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc是一家总部设在美国的生物技术公司，专注于发现、开发和商业化用于治疗疾病的一流生物疗法，重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122391098e3d8e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122391098e3d8e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CAPR"],"gpt_icon":0},{"id":"2477383856","title":"美国研究综述-中心空间、吉利德、Gitlab","url":"https://stock-news.laohu8.com/highlight/detail?id=2477383856","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477383856?lang=zh_cn&edition=full","pubTime":"2024-10-21 19:25","pubTimestamp":1729509951,"startTime":"0","endTime":"0","summary":"    路透10月21日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 Centerspace、Gilead 和 Gitlab。* 吉利德  ：Leerink Partners将其评级从 \"跑赢大盘 \"上调至 \"跑赢大盘\"。* Gitlab Inc   ：Needham将其评级从 \"持有 \"上调至 \"买入 * Liberty Energy Inc   ：花旗集团将其评级从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCB","CIVI","AXP","APA","AN","CVS","DD","UPST","DTE","FANG","LU1057294990.SGD","LU2362541513.USD","BTAI","BANF","GTLB","LU1989764664.SGD","ANAB","BKV","CCK","CSR","ACLX","AR","CAPR","ELV","DVN","BLMN","CPAY","RCUS","BWA","LU2449327464.USD","PLAY","ARRY","LNG","ALLY","CHRD","AMZN","CAKE","DDOG","BK4532","EAT","IE00BJTD4N35.SGD","IE00BWXC8680.SGD","LU0061474960.USD","NFLX","OZK","PINE","CMA","LU1267930227.SGD","AES","BSX","CTRA"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.capricor.com","stockEarnings":[{"period":"1week","weight":-0.1208},{"period":"1month","weight":-0.3188},{"period":"3month","weight":1.509},{"period":"6month","weight":1.6638},{"period":"1year","weight":1.9598},{"period":"ytd","weight":1.5603}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Capricor Therapeutics, Inc.在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，专注于开发转化细胞和外泌体疗法，用于治疗Duchenne肌营养不良症（DMD），这是一种罕见的肌肉营养不良症，会导致肌肉退化和过早死亡，以及其他医疗需求未得到满足的疾病。自成立以来，该公司投入了大量资源开发CAP-1002和他们的其他候选产品，包括他们的外泌体平台，开发他们的制造流程，为公司配备人员，并为这些业务提供行政支持。该公司没有任何获准销售的产品。公司能否最终产生足以实现盈利的任何产品收入，将取决于用于治疗DMD和其他候选产品的CAP-1002的成功开发、批准和最终商业化。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.171511},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.017849},{"month":3,"riseRate":0.555556,"avgChangeRate":0.019788},{"month":4,"riseRate":0.4,"avgChangeRate":0.465721},{"month":5,"riseRate":0.3,"avgChangeRate":-0.145751},{"month":6,"riseRate":0.6,"avgChangeRate":0.038271},{"month":7,"riseRate":0.4,"avgChangeRate":0.099816},{"month":8,"riseRate":0.6,"avgChangeRate":0.032614},{"month":9,"riseRate":0.4,"avgChangeRate":0.368975},{"month":10,"riseRate":0.1,"avgChangeRate":-0.099537},{"month":11,"riseRate":0.4,"avgChangeRate":-0.086131},{"month":12,"riseRate":0.1,"avgChangeRate":-0.137519}],"exchange":"NASDAQ","name":"Capricor Therapeutics Inc","nameEN":"Capricor Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Capricor Therapeutics Inc(CAPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Capricor Therapeutics Inc,CAPR,Capricor Therapeutics Inc股票,Capricor Therapeutics Inc股票老虎,Capricor Therapeutics Inc股票老虎国际,Capricor Therapeutics Inc行情,Capricor Therapeutics Inc股票行情,Capricor Therapeutics Inc股价,Capricor Therapeutics Inc股市,Capricor Therapeutics Inc股票价格,Capricor Therapeutics Inc股票交易,Capricor Therapeutics Inc股票购买,Capricor Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Capricor Therapeutics Inc(CAPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}